AXSOME THERAPEUTICS, INC. (AXSM) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -191.64M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-191.64M | (m) |
| 2026-03-31 | (m) | $-188.30M | (m) |
| 2025-12-31 | (m) | $-183.17M | (m) |
| 2025-09-30 | (m) | $-229.53M | (m) |
| 2025-06-30 | (m) | $-246.90M | (m) |
| 2025-03-31 | (m) | $-278.27M | (m) |
| 2024-12-31 | (m) | $-287.22M | (m) |
| 2024-09-30 | (m) | $-310.95M | (m) |
| 2024-06-30 | (m) | $-308.55M | (m) |
| 2024-03-31 | (m) | $-296.38M | (m) |
| 2023-12-31 | (m) | $-239.24M | (m) |
| 2023-09-30 | (m) | $-201.83M | (m) |
| 2023-06-30 | (m) | $-184.45M | (m) |
| 2023-03-31 | (m) | $-158.72M | (m) |
| 2022-12-31 | (m) | $-187.13M | (m) |
| 2022-09-30 | (m) | $-159.87M | (m) |
| 2022-06-30 | (m) | $-149.93M | (m) |
| 2022-03-31 | (m) | $-140.78M | (m) |
| 2021-12-31 | (m) | $-130.40M | (m) |
| 2021-09-30 | (m) | $-125.59M | (m) |
| 2021-06-30 | (m) | $-113.63M | (m) |
| 2021-03-31 | (m) | $-99.68M | (m) |
| 2020-12-31 | (m) | $-102.90M | (m) |
| 2020-09-30 | (m) | $-98.54M | (m) |
| 2020-06-30 | (m) | $-94.75M | (m) |
| 2020-03-31 | (m) | $-90.19M | (m) |
| 2019-12-31 | (m) | $-68.35M | (m) |
| 2019-09-30 | (m) | $-53.14M | (m) |
| 2019-06-30 | (m) | $-42.28M | (m) |
| 2019-03-31 | (m) | $-36.80M | (m) |
| 2018-12-31 | (m) | $-30.97M | (m) |
| 2018-09-30 | (m) | $-28.80M | (m) |
| 2018-06-30 | (m) | $-26.95M | (m) |
| 2018-03-31 | (m) | $-25.75M | (m) |
| 2017-12-31 | (m) | $-28.94M | (m) |
| 2017-09-30 | (m) | $-28.84M | (m) |
| 2017-06-30 | (m) | $-29.60M | (m) |
| 2017-03-31 | (m) | $-29.33M | (m) |
| 2016-12-31 | (m) | $-27.20M | (m) |
| 2016-09-30 | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) |
| 2015-12-31 | (m) | $-12.21M | (m) |
| 2015-09-30 | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) |
| 2014-12-31 | (m) | $-6.00M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |